BRISBANE, Calif., Oct. 16, 2017 -- Cutera, Inc. (Nasdaq:CUTR) (“Cutera” or the “Company”), a leading provider of laser, light and other energy-based aesthetic systems for practitioners worldwide, announces their 2017 Medical Advisory Board members. Cutera’s Medical Advisory Board will meet on October 20, 2017, and be led by Jeffrey Dover, MD, FRCPC, Associate Professor of Clinical Dermatology at Yale University School of Medicine, and Associate Professor of Dermatology at Brown Medical School. Accompanying Dr. Dover are five renowned physicians:
- Neil Sadick, M.D., Board Certified Dermatologist and Founder of Sadick Dermatology, Clinical Professor of Dermatology at Weill Cornell Medical College;
- E. Victor Ross, M.D., Board Certified Dermatologist at Scipps Clinic, Specializing in Laser Surgery, Cosmetic and General Dermatology;
- Jeffrey Hsu, M.D., Board Certified Dermatologist and Co-Director of Dermatologic, Cosmetic & Laser Surgery at The Dermatology Institute of DuPage Medical Group, and Associate Professor at University of Illinois at Chicago;
- Omar Ibrahimi, M.D., Ph.D., Board Certified Dermatologist and Founder and Medical Director of The Connecticut Skin Institute; and
- Rick Green, M.D., FACS, Board Certified Plastic Surgeon and Medical Director at Salmon Creek Plastic Surgery.
“We are honored to welcome this prestigious group of key opinion leaders to our Medical Advisory Board,” said James Reinstein, President and CEO at CUTERA. “Our team looks forward to the valuable insights that come from the country’s leading practitioners in the application and use of aesthetic lasers. As an organization we are eager to apply what we learn to our business moving forward.”
In discussion surrounding the future of lasers and aesthetics, the Medical Advisory Board will offer insights and direction to help Cutera with its future product pipeline. “We look forward to obtaining practitioner perspectives and field-based insights. We expect this group of key opinion leaders to help us discover new market trends,” said Michael Karavitis, Executive Vice President and Chief Technology Officer at Cutera. “This and subsequent meetings serve as an opportunity to receive invaluable guidance for building truly innovative lasers.”
About Cutera, Inc.
Brisbane, California-based Cutera is a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide. Since 1998, Cutera has been developing innovative, easy-to-use products that enable physicians and other qualified practitioners to offer safe and effective aesthetic treatments to their patients. For more information, call 1-888-4CUTERA or visit www.cutera.com.
CONTACTS:
Cutera, Inc.
Sandra A. Gardiner
Chief Financial Officer (Consulting)
415-657-5500
Investor Relations
John Mills
ICR, Inc.
646-277-1254
[email protected]


Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026
Boeing Secures Multi-Billion Dollar Defense Contracts for F-15IA Jets and E-4B Aircraft Support
Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change 



